Skip to main content

Are you a legal professional? Visit our professional site

Search for legal issues
For help near (city, ZIP code or county)
Please enter a legal issue and/or a location

LeFaivre v. KV Pharm. Co., No. 10-1326

Article Placeholder Image
By FindLaw Staff on January 20, 2011 4:28 PM

Tort Action Against Pharmaceutical Company

In LeFaivre v. KV Pharm. Co., No. 10-1326, an action alleging that a pharmaceutical company breached its implied warranty of merchantability and violated the Missouri Merchantability Practices Act (MMPA) by failing to manufacture a medication in compliance with federal regulations, the court reversed the dismissal of the action where federal law did not preempt plaintiff's MMPA claims.

 

As the court wrote:  "Allen Lefaivre, individually and on behalf of all others similarly situated, brought this potential class action suit against KV Pharmaceutical Company, ETHEX Corporation, and Ther-Rx Corporation (collectively, "KV"). KV manufactures a hypertension medication called Metoprolol Succinate ER. Lefaivre alleged that KV breached its implied warranty of merchantability and violated the Missouri Merchantability Practices Act (MMPA) by failing to manufacture the medication in compliance with federal regulations."

Related Resources

Find a Lawyer

More Options